Cannabis Stocks Icon

Cannabis Stocks

Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.

Recent Cannabis Stocks Articles

AKAN Stock Pops as Akanda Eyes Entry into German Cannabis Market

Akanda stock is rising higher on Friday after the cannabis company told AKAN investors it wants to expand its business into Germany.

3 Cannabis Stocks on the Brink of a Massive Breakout

These cannabis stocks to buy offer legalization upside but include diversified revenue streams to shield your portfolio from instability.

The 5 Biggest Buyers of Tilray (TLRY) Stock

TLRY stock is falling lower after it reported a weak earnings report. Here are the top buyers of the cannabis company.

TLRY Stock Alert: Cannabis Legalization Hopes May Not Be Enough for Tilray

Tilray's beer business is growing faster than its pot business and is showing increased profits amid a cannabis cash slump

Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for April 2024 

Cannabis stocks could see higher highs. All thanks to legalization in Germany, and growing approval ratings in polls ahead of elections.

CGC Stock: What to Know Ahead of Canopy Growth’s Share Conversion Vote This Week

CGC stockholders will vote to create a new class of exchangeable shares on April 12. These shares will represent Canopy USA.

The 5 Biggest Buyers of Canopy Growth (CGC) Stock

CGC stock has been on an absolute tear as President Joe Biden and Vice President Kamala Harris have echoed their support for legalization.

FLGC Stock: Why Flora Growth Is Down 15% Despite Major Cannabis Rally

Flora Growth hopes to become a big deal in Germany, which recently decriminalized recreational cannabis use.

Cannabis Stocks Alert: 3 Big Reasons TLRY, ACB, CGC and SNDL Keep Gaining

The biggest pot players are still not profitable, but there are some interesting penny stocks that are making money.

Why Is Tilray (TLRY) Stock Up 18% Today?

Tilray Brands is surging today as Canada prepares to adopt new policies. Here's why this is good news for TLRY stock.

The 3 Most Undervalued Cannabis Stocks to Buy in April 2024

These are the most undervalued cannabis stocks to buy in April as they represent companies with improving margins and a healthy growth outlook

The 3 Best Cannabis Stocks to Buy in April 2024

Cannabis may be a controversial investment but it may also be profitable for some of the best cannabis stocks to buy for April.

Cannabis Stocks Light Up As Florida Adds Weed to November Ballots

Cannabis stocks are up Tuesday after the Florida Supreme Court allowed a recreational marijuana amendment on the November ballot.

3 Penny Stocks on the Brink of Greatness

Seeking penny stocks to buy? Explore Bitfarms' Bitcoin leverage, Tilray's innovative market share growth, and Nokia's tech-forward strategy.

Dear CGC Stock Fans, Mark Your Calendars for April 12

Canopy will hold a special meeting on April 12 in order to receive approval for creating a new class of shares for Canopy USA.

From Spare Change to Stock Market Gains: 3 Stocks to Buy With Your Last $10

The stock market has been opened to investors large or small, even those looking for stocks to buy with $10.

Cannabis Stocks Alert: Recreational Marijuana Just Became Legal in Germany

Cannabis stocks are on the move Monday as investors react to the news that recreational marijuana is now legal in Germany.

The $1K to $10K Formula: 3 Stocks to Supercharge Your Returns in 10 Years

Looking for stocks to supercharge your returns? Check out these three sleeper companies with excellent growth potential.

The 3 Best Cannabis Stocks to Buy in Q2 2024

Seize opportunities in the best cannabis stocks to buy, benefiting from global legalization and U.S. policy shifts offering solid upside.